Form 4: MODD Director Sheibley Granted Stock Options

Sentiment:

Insider Transaction Report


Modular Medical, Inc. Director Philip Brent Sheibley was granted 7,500 stock options at an exercise price of $0.7, fully vested on September 30, 2025.

Summary

  • Philip Brent Sheibley, a Director of Modular Medical, Inc. (MODD), acquired 7,500 derivative securities in the form of options to purchase common stock.
  • The options have an exercise price of $0.7 per share.
  • The grant date for these options was September 30, 2025.
  • The options were fully vested and exercisable on the grant date, September 30, 2025.
  • The expiration date for these options is September 30, 2035.
  • The options were granted in accordance with Modular Medical, Inc.'s Outside Director Compensation Plan.

Sentiment

Score: 7

Explanation: The grant of stock options to a director is a standard compensation practice that generally aligns the director's interests with shareholders, which is a positive for corporate governance and long-term value creation. It does not indicate any immediate financial performance or operational changes, hence a moderately positive sentiment.

Positives

  • The grant of stock options to a director aligns management's interests with those of shareholders, incentivizing long-term company performance.
  • The options were fully vested and exercisable on the grant date, providing immediate equity exposure and incentive.

Future Outlook

This filing is a report of an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

The granting of stock options to outside directors is a common practice across various industries, serving as a standard component of executive and director compensation packages to attract and retain talent and align their financial interests with shareholder value creation.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Plan ImplementationThe option grant was made in accordance with the Issuer's Outside Director Compensation Plan, indicating a structured approach to director remuneration.09/30/2025Reinforces established corporate governance practices for director compensation, promoting transparency and alignment of interests.

Related Party Transactions

  • The grant of stock options to Director Philip Brent Sheibley constitutes a transaction with a related party, executed under the company's established Outside Director Compensation Plan.

Stakeholder Impact

  • Shareholders: The option grant aligns the director's financial incentives with shareholder value, potentially leading to more focused efforts on long-term company growth.
  • Director: Provides a direct equity stake and incentive for the director to contribute to the company's success.

Key Dates

DateDescription
09/30/2025Date of earliest transaction, option grant date, and date options became fully vested and exercisable.
10/02/2025Signature date of the reporting person's attorney-in-fact.
09/30/2035Expiration date of the granted stock options.

Keywords

Modular Medical, MODD, Philip Sheibley, stock options, director compensation, SEC Form 4, insider transaction, equity incentive

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.